
Doctor Tian Zhao
University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)
Follow
Contributor content
Presentation
Low dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndrome (LILACS)
Presentation

